Literature DB >> 15220457

Functional analysis of late-budding domain activity associated with the PSAP motif within the vesicular stomatitis virus M protein.

Takashi Irie1, Jillian M Licata, Himangi R Jayakar, Michael A Whitt, Peter Bell, Ronald N Harty.   

Abstract

A PPPY motif within the M protein of vesicular stomatitis virus (VSV) functions as a late-budding domain (L-domain); however, L-domain activity has yet to be associated with a downstream PSAP motif. VSV recombinants with mutations in the PPPY and/or PSAP motif were recovered by reverse genetics and examined for growth kinetics, plaque size, and budding efficiency by electron microscopy. Results indicate that unlike the PPPY motif, the PSAP motif alone does not possess L-domain activity. Finally, the insertion of the human immunodeficiency virus type 1 p6 L-domain and flanking sequences into the PSAP region of M protein rescued budding of a PPPY mutant of VSV to wild-type levels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15220457      PMCID: PMC434086          DOI: 10.1128/JVI.78.14.7823-7827.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding.

Authors:  J E Garrus; U K von Schwedler; O W Pornillos; S G Morham; K H Zavitz; H E Wang; D A Wettstein; K M Stray; M Côté; R L Rich; D G Myszka; W I Sundquist
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

2.  Ebola virus VP40-induced particle formation and association with the lipid bilayer.

Authors:  L D Jasenosky; G Neumann; I Lukashevich; Y Kawaoka
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.

Authors:  M A Accola; B Strack; H G Göttlinger
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

4.  Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking.

Authors:  M Babst; G Odorizzi; E J Estepa; S D Emr
Journal:  Traffic       Date:  2000-03       Impact factor: 6.215

5.  Vesicular release of ebola virus matrix protein VP40.

Authors:  J Timmins; S Scianimanico; G Schoehn; W Weissenhorn
Journal:  Virology       Date:  2001-04-25       Impact factor: 3.616

6.  Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag).

Authors:  L VerPlank; F Bouamr; T J LaGrassa; B Agresta; A Kikonyogo; J Leis; C A Carter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

7.  Late domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimeras.

Authors:  R C Craven; R N Harty; J Paragas; P Palese; J W Wills
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

8.  A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding.

Authors:  R N Harty; J Paragas; M Sudol; P Palese
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

9.  p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.

Authors:  M Huang; J M Orenstein; M A Martin; E O Freed
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones.

Authors:  S P Whelan; L A Ball; J N Barr; G T Wertz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

View more
  21 in total

1.  Viral infection: Moving through complex and dynamic cell-membrane structures.

Authors:  Jonathan Barroso-González; Laura García-Expósito; Julià Blanco; Agustín Valenzuela-Fernández; Isabel Puigdomènech; Laura de Armas-Rillo; José-David Machado
Journal:  Commun Integr Biol       Date:  2011-07-01

2.  Ubiquitin depletion and dominant-negative VPS4 inhibit rhabdovirus budding without affecting alphavirus budding.

Authors:  Gwen M Taylor; Phyllis I Hanson; Margaret Kielian
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

3.  Expression, purification and crystallization of a lyssavirus matrix (M) protein.

Authors:  René Assenberg; Olivier Delmas; Stephen C Graham; Anil Verma; Nick Berrow; David I Stuart; Raymond J Owens; Hervé Bourhy; Jonathan M Grimes
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-03-21

4.  Influenza virus budding does not require a functional AAA+ ATPase, VPS4.

Authors:  Rie Watanabe; Robert A Lamb
Journal:  Virus Res       Date:  2010-07-17       Impact factor: 3.303

5.  Small-molecule probes targeting the viral PPxY-host Nedd4 interface block egress of a broad range of RNA viruses.

Authors:  Ziying Han; Jianhong Lu; Yuliang Liu; Benjamin Davis; Michael S Lee; Mark A Olson; Gordon Ruthel; Bruce D Freedman; Matthias J Schnell; Jay E Wrobel; Allen B Reitz; Ronald N Harty
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

6.  L-domain flanking sequences are important for host interactions and efficient budding of vesicular stomatitis virus recombinants.

Authors:  Takashi Irie; Ronald N Harty
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

7.  Ebola virus VP40 late domains are not essential for viral replication in cell culture.

Authors:  Gabriele Neumann; Hideki Ebihara; Ayato Takada; Takeshi Noda; Darwyn Kobasa; Luke D Jasenosky; Shinji Watanabe; Jin H Kim; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 8.  Membrane budding.

Authors:  James H Hurley; Evzen Boura; Lars-Anders Carlson; Bartosz Różycki
Journal:  Cell       Date:  2010-12-10       Impact factor: 41.582

9.  Vesicular stomatitis virus matrix protein mutations that affect association with host membranes and viral nucleocapsids.

Authors:  Brooke Dancho; Margie O McKenzie; John H Connor; Douglas S Lyles
Journal:  J Biol Chem       Date:  2008-12-16       Impact factor: 5.157

10.  Quinoxaline-based inhibitors of Ebola and Marburg VP40 egress.

Authors:  H Marie Loughran; Ziying Han; Jay E Wrobel; Sarah E Decker; Gordon Ruthel; Bruce D Freedman; Ronald N Harty; Allen B Reitz
Journal:  Bioorg Med Chem Lett       Date:  2016-06-23       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.